METHODS: A two-pronged strategy was used by evaluating data from peer-reviewed literature and official reports. A systematic search was conducted using a structured query in four databases (Web of Science, Scopus, Medline, and PubMed) to identify any reports of the occurrence of zoonotic TB. No language and time constraints were used during the search, but non-English language articles were later excluded. The official data were sourced from the World Organization for Animal Health's (WOAH) World Animal Health Information System (WAHIS) and WHO's global TB database.
RESULTS: The retrieved records from SEAR and WPR (n = 113) were screened for eligibility, and data about disease occurrence were extracted and tabulated. In SEAR, all of the five studies that conducted Mycobacterium speciation (5/6) in humans were from India, and the reported Mycobacterium species included M. tuberculosis, M. bovis, M. scrofulacium, M. kansasii, M. phlei, M. smegmatis and M. orygis. In WPR, Mycobacterium speciation investigations in humans were conducted in Australia (8), China (2), Japan (2), NewZealand (2) and Malaysia (1), and the reported Mycobacterium species included M. bovis, M. africanum and M. tuberculosis. Seven countries in WHO's SEAR have officially reported the occurrence of Mycobacterium bovis in their animals: Bangladesh, India, Indonesia, Myanmar, Nepal, Sri Lanka and Thailand. In WPR, the WAHIS information system includes reports of the identification of M. bovis from 11 countries - China, Fiji, Japan, Malaysia, Mongolia, New Zealand, the Philippines, the Republic of Korea, Singapore, Tonga and Viet Nam. In contrast, human zoonotic TB cases in the WHO database were only listed from Australia, Brunei Darussalam and Palau countries.
DISCUSSION: The available data suggests under-reporting of zoonotic TB in the regions. Efforts are required to strengthen zoonotic TB surveillance systems from both animal and human health sides to better understand the impact of zoonotic TB in order to take appropriate action to achieve the goal of ending the TB epidemic.
AIM: This study aimed to identify the reactor and evaluate the results of a Brucella abortus vaccination in the Malaka Regency.
METHODS: This research method involves the first stage, which involves sampling serum from 100 cattle. Serum specimens are derived from blood taken from the jugular or coccygeal vein using a Vacutainer tube filled with silicone and left at room temperature until the blood is separated into serum and clot. Then, for serological tests in the form of the Rose Bengal test (RBT), if the RBT test is positive, followed by the complement fixation test (CFT) test, and the CFT test is also positive, the patient is designated as a brucellosis reactor. At the same time, if the CFT is positive in vaccinated cattle, the vaccination is considered successful, and if it is negative, it is necessary to reevaluate the immunization.
RESULT: The results of 100 samples showed that the RBT and CFT tests yielded two distinct outcomes: a positive RBT and a negative CFT test, indicating that no B. abortus reactors were detected.
CONCLUSION: Cattle in Malacca Regency were not found to be positive for the B. abortus reactor. Vaccination results against Brucella are not optimal, as indicated by the absence of an antibody response, as determined by RBT and CFT tests.